|
Volumn 19, Issue 9, 1999, Pages
|
Low-molecular-weight heparins for acute coronary syndromes: An emergency medicine perspective
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CREATINE KINASE MB;
DALTEPARIN;
ENOXAPARIN;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
LOW MOLECULAR WEIGHT HEPARIN;
NITRATE;
TROPONIN T;
ACUTE HEART INFARCTION;
ANGINA PECTORIS;
ARTICLE;
BLEEDING;
CLINICAL PATHWAY;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
DRUG CHOICE;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
EMERGENCY HEALTH SERVICE;
HOSPITALIZATION;
HUMAN;
INTENSIVE CARE UNIT;
INTRAVENOUS DRUG ADMINISTRATION;
PATIENT MONITORING;
QUALITY OF LIFE;
SUBCUTANEOUS DRUG ADMINISTRATION;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT PLANNING;
ACUTE DISEASE;
ANGINA, UNSTABLE;
CLINICAL TRIALS;
CORONARY DISEASE;
EMERGENCY MEDICAL SERVICES;
HEPARIN;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
MYOCARDIAL INFARCTION;
TIME FACTORS;
|
EID: 0032827845
PISSN: 02770008
EISSN: None
Source Type: Journal
DOI: 10.1592/phco.19.14.155S.31704 Document Type: Article |
Times cited : (3)
|
References (32)
|